A rapid flp-in system for expression of secreted h5n1 influenza hemagglutinin vaccine immunogen in mammalian cells

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Lu, Hanxin ^a   Khurana, Surender ^a   Verma, Nitin ^a   Manischewitz, Jody ^a   King, Lisa ^a   Beigel, John H ^b   Golding, Hana ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CELL LINE; CROSS REACTION; FLP IN SYSTEM; GENE EXPRESSION SYSTEM; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VIRUS A H5N1; MAMMAL CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; VIRUS STRAIN; ANIMAL; EVALUATION; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; MAMMAL; METABOLISM; METHODOLOGY; MOLECULAR CLONING; PHYSIOLOGY; RABBIT; SERODIAGNOSIS; SYNTHESIS; TRANSGENE;

MAMMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; CELL LINE; CLONING, MOLECULAR; GENE EXPRESSION; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MAMMALS; NEUTRALIZATION TESTS; RABBITS; TRANSFECTION; TRANSGENES;

EID: 79952228974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017297     Document Type: Article

References (23)

1. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M, (2006) Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354: 1343-1351.
2. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, et al. (2004) Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303: 1866-1870.
3. Wei CJ, Xu L, Kong WP, Shi W, Canis K, et al. (2008) Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol 82: 6200-6208.
4. Graslund S, Nordlund P, Weigelt J, Hallberg BM, Bray J, et al. (2008) Protein production and purification. Nat Methods 5: 135-146.
5. Bosch BJ, Bodewes R, de Vries RP, Kreijtz JH, Bartelink W, et al. Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol 84: 10366-10374.
6. Lakey DL, Treanor JJ, Betts RF, Smith GE, Thompson J, et al. (1996) Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis 174: 838-841.
7. Wang K, Holtz KM, Anderson K, Chubet R, Mahmoud W, et al. (2006) Expression and purification of an influenza hemagglutinin-one step closer to a recombinant protein-based influenza vaccine. Vaccine 24: 2176-2185.
8. Huang Y, Li Y, Wang YG, Gu X, Wang Y, et al. (2007) An efficient and targeted gene integration system for high-level antibody expression. J Immunol Methods 322: 28-39.
9. Wiberg FC, Rasmussen SK, Frandsen TP, Rasmussen LK, Tengbjerg K, et al. (2006) Production of target-specific recombinant human polyclonal antibodies in mammalian cells. Biotechnol Bioeng 94: 396-405.
10. Wiesner O, Litwiller RD, Hummel AM, Viss MA, McDonald CJ, et al. (2005) Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments. FEBS Lett 579: 5305-5312.
11. Kuhl A, Korkmaz B, Utecht B, Kniepert A, Schonermarck U, et al. Mapping of conformational epitopes on human proteinase 3, the autoantigen of Wegener's granulomatosis. J Immunol 185: 387-399.
12. Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, et al. (2009) Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med 6: e1000049.
13. Khurana S, Chearwae W, Castellino F, Manischewitz J, King LR, et al. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci Transl Med 2: 15ra15.
14. Beigel JH, Voell J, Huang CY, Burbelo PD, Lane HC, (2009) Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine. J Infect Dis 200: 501-509.
15. Bernstein DI, Edwards KM, Dekker CL, Belshe R, Talbot HK, et al. (2008) Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults. J Infect Dis 197: 667-675.
16. Carmona A, Omenaca F, Tejedor JC, Merino JM, Vaman T, et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. Vaccine 28: 5837-5844.
17. Stephenson I, Nicholson KG, Hoschler K, Zambon MC, Hancock K, et al. (2008) Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. N Engl J Med 359: 1631-1633.
18. Durocher Y, Butler M, (2009) Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol 20: 700-707.
19. Suguitan AL Jr, Marino MP, Desai PD, Chen LM, Matsuoka Y, et al. (2009) The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus. Virology 395: 280-288.
20. Cornelissen LA, de Vries RP, de Boer-Luijtze EA, Rigter A, Rottier PJ, et al. (2010) A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One 5: e10645.
21. van den Berg T, Lambrecht B, Marche S, Steensels M, Van Borm S, et al. (2008) Influenza vaccines and vaccination strategies in birds. Comp Immunol Microbiol Infect Dis 31: 121-165.
22. Steensels M, Van Borm S, Lambrecht B, De Vriese J, Le Gros FX, et al. (2007) Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge. Avian Dis 51: 325-331.
23. Kim JK, Seiler P, Forrest HL, Khalenkov AM, Franks J, et al. (2008) Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks. J Virol 82: 11374-11382.